Clinical trial
Pilot Study on the Treatment of Vunakizumab in Mild to Moderate Systemic Lupus Erythematosus
NCT06881290 is registered in ClinicalTrials.gov with Chinese SLE Treatment And Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study on the Treatment of Vunakizumab in Mild to Moderate Systemic Lupus Erythematosus
- Lead sponsor
- Chinese SLE Treatment And Research Group
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- May 19, 2025
- Completion date
- December 1, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.